世界のヘマグルチニン5市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemagglutinin 5 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5771
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ヘマグルチニン5の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VGX-3400X、IY-7640、INO-3510、DPC-005、その他）、用途別市場規模（診療所、病院、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ヘマグルチニン5の市場動向
・企業の競争状況、市場シェア
・ヘマグルチニン5の種類別市場規模と予測2016-2027（VGX-3400X、IY-7640、INO-3510、DPC-005、その他）
・ヘマグルチニン5の用途別市場規模と予測2016-2027（診療所、病院、家庭用）
・ヘマグルチニン5の北米市場規模2016-2027（アメリカ、カナダ）
・ヘマグルチニン5の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ヘマグルチニン5のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ヘマグルチニン5の中南米市場規模2016-2027（メキシコ、ブラジル）
・ヘマグルチニン5の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Altravax, Inc.、Ilyang Pharmaceutical Co., Ltd、Inovio Pharmaceuticals, Inc.、NewLink Genetics Corporation、Vaxine Pty Ltd）
・結論

Market Analysis and Insights: Global Hemagglutinin 5 Market
The global Hemagglutinin 5 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemagglutinin 5 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemagglutinin 5 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemagglutinin 5 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemagglutinin 5 market.

Global Hemagglutinin 5 Scope and Market Size
Hemagglutinin 5 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemagglutinin 5 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
VGX-3400X
IY-7640
INO-3510
DPC-005
Others

Segment by Application
Clinic
Hospital
House Use

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Altravax, Inc.
Ilyang Pharmaceutical Co., Ltd
Inovio Pharmaceuticals, Inc.
NewLink Genetics Corporation
Vaxine Pty Ltd

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemagglutinin 5 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 VGX-3400X
1.2.3 IY-7640
1.2.4 INO-3510
1.2.5 DPC-005
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hemagglutinin 5 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 House Use
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemagglutinin 5 Market Perspective (2016-2027)
2.2 Hemagglutinin 5 Growth Trends by Regions
2.2.1 Hemagglutinin 5 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemagglutinin 5 Historic Market Share by Regions (2016-2021)
2.2.3 Hemagglutinin 5 Forecasted Market Size by Regions (2022-2027)
2.3 Hemagglutinin 5 Industry Dynamic
2.3.1 Hemagglutinin 5 Market Trends
2.3.2 Hemagglutinin 5 Market Drivers
2.3.3 Hemagglutinin 5 Market Challenges
2.3.4 Hemagglutinin 5 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemagglutinin 5 Players by Revenue
3.1.1 Global Top Hemagglutinin 5 Players by Revenue (2016-2021)
3.1.2 Global Hemagglutinin 5 Revenue Market Share by Players (2016-2021)
3.2 Global Hemagglutinin 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemagglutinin 5 Revenue
3.4 Global Hemagglutinin 5 Market Concentration Ratio
3.4.1 Global Hemagglutinin 5 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemagglutinin 5 Revenue in 2020
3.5 Hemagglutinin 5 Key Players Head office and Area Served
3.6 Key Players Hemagglutinin 5 Product Solution and Service
3.7 Date of Enter into Hemagglutinin 5 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemagglutinin 5 Breakdown Data by Type
4.1 Global Hemagglutinin 5 Historic Market Size by Type (2016-2021)
4.2 Global Hemagglutinin 5 Forecasted Market Size by Type (2022-2027)

5 Hemagglutinin 5 Breakdown Data by Application
5.1 Global Hemagglutinin 5 Historic Market Size by Application (2016-2021)
5.2 Global Hemagglutinin 5 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemagglutinin 5 Market Size (2016-2027)
6.2 North America Hemagglutinin 5 Market Size by Type
6.2.1 North America Hemagglutinin 5 Market Size by Type (2016-2021)
6.2.2 North America Hemagglutinin 5 Market Size by Type (2022-2027)
6.2.3 North America Hemagglutinin 5 Market Size by Type (2016-2027)
6.3 North America Hemagglutinin 5 Market Size by Application
6.3.1 North America Hemagglutinin 5 Market Size by Application (2016-2021)
6.3.2 North America Hemagglutinin 5 Market Size by Application (2022-2027)
6.3.3 North America Hemagglutinin 5 Market Size by Application (2016-2027)
6.4 North America Hemagglutinin 5 Market Size by Country
6.4.1 North America Hemagglutinin 5 Market Size by Country (2016-2021)
6.4.2 North America Hemagglutinin 5 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hemagglutinin 5 Market Size (2016-2027)
7.2 Europe Hemagglutinin 5 Market Size by Type
7.2.1 Europe Hemagglutinin 5 Market Size by Type (2016-2021)
7.2.2 Europe Hemagglutinin 5 Market Size by Type (2022-2027)
7.2.3 Europe Hemagglutinin 5 Market Size by Type (2016-2027)
7.3 Europe Hemagglutinin 5 Market Size by Application
7.3.1 Europe Hemagglutinin 5 Market Size by Application (2016-2021)
7.3.2 Europe Hemagglutinin 5 Market Size by Application (2022-2027)
7.3.3 Europe Hemagglutinin 5 Market Size by Application (2016-2027)
7.4 Europe Hemagglutinin 5 Market Size by Country
7.4.1 Europe Hemagglutinin 5 Market Size by Country (2016-2021)
7.4.2 Europe Hemagglutinin 5 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemagglutinin 5 Market Size (2016-2027)
8.2 Asia-Pacific Hemagglutinin 5 Market Size by Type
8.2.1 Asia-Pacific Hemagglutinin 5 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemagglutinin 5 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemagglutinin 5 Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemagglutinin 5 Market Size by Application
8.3.1 Asia-Pacific Hemagglutinin 5 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemagglutinin 5 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemagglutinin 5 Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemagglutinin 5 Market Size by Region
8.4.1 Asia-Pacific Hemagglutinin 5 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemagglutinin 5 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemagglutinin 5 Market Size (2016-2027)
9.2 Latin America Hemagglutinin 5 Market Size by Type
9.2.1 Latin America Hemagglutinin 5 Market Size by Type (2016-2021)
9.2.2 Latin America Hemagglutinin 5 Market Size by Type (2022-2027)
9.2.3 Latin America Hemagglutinin 5 Market Size by Type (2016-2027)
9.3 Latin America Hemagglutinin 5 Market Size by Application
9.3.1 Latin America Hemagglutinin 5 Market Size by Application (2016-2021)
9.3.2 Latin America Hemagglutinin 5 Market Size by Application (2022-2027)
9.3.3 Latin America Hemagglutinin 5 Market Size by Application (2016-2027)
9.4 Latin America Hemagglutinin 5 Market Size by Country
9.4.1 Latin America Hemagglutinin 5 Market Size by Country (2016-2021)
9.4.2 Latin America Hemagglutinin 5 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemagglutinin 5 Market Size (2016-2027)
10.2 Middle East & Africa Hemagglutinin 5 Market Size by Type
10.2.1 Middle East & Africa Hemagglutinin 5 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemagglutinin 5 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemagglutinin 5 Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemagglutinin 5 Market Size by Application
10.3.1 Middle East & Africa Hemagglutinin 5 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemagglutinin 5 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemagglutinin 5 Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemagglutinin 5 Market Size by Country
10.4.1 Middle East & Africa Hemagglutinin 5 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemagglutinin 5 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Altravax, Inc.
11.1.1 Altravax, Inc. Company Details
11.1.2 Altravax, Inc. Business Overview
11.1.3 Altravax, Inc. Hemagglutinin 5 Introduction
11.1.4 Altravax, Inc. Revenue in Hemagglutinin 5 Business (2016-2021)
11.1.5 Altravax, Inc. Recent Development
11.2 Ilyang Pharmaceutical Co., Ltd
11.2.1 Ilyang Pharmaceutical Co., Ltd Company Details
11.2.2 Ilyang Pharmaceutical Co., Ltd Business Overview
11.2.3 Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Introduction
11.2.4 Ilyang Pharmaceutical Co., Ltd Revenue in Hemagglutinin 5 Business (2016-2021)
11.2.5 Ilyang Pharmaceutical Co., Ltd Recent Development
11.3 Inovio Pharmaceuticals, Inc.
11.3.1 Inovio Pharmaceuticals, Inc. Company Details
11.3.2 Inovio Pharmaceuticals, Inc. Business Overview
11.3.3 Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Introduction
11.3.4 Inovio Pharmaceuticals, Inc. Revenue in Hemagglutinin 5 Business (2016-2021)
11.3.5 Inovio Pharmaceuticals, Inc. Recent Development
11.4 NewLink Genetics Corporation
11.4.1 NewLink Genetics Corporation Company Details
11.4.2 NewLink Genetics Corporation Business Overview
11.4.3 NewLink Genetics Corporation Hemagglutinin 5 Introduction
11.4.4 NewLink Genetics Corporation Revenue in Hemagglutinin 5 Business (2016-2021)
11.4.5 NewLink Genetics Corporation Recent Development
11.5 Vaxine Pty Ltd
11.5.1 Vaxine Pty Ltd Company Details
11.5.2 Vaxine Pty Ltd Business Overview
11.5.3 Vaxine Pty Ltd Hemagglutinin 5 Introduction
11.5.4 Vaxine Pty Ltd Revenue in Hemagglutinin 5 Business (2016-2021)
11.5.5 Vaxine Pty Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemagglutinin 5 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of VGX-3400X
Table 3. Key Players of IY-7640
Table 4. Key Players of INO-3510
Table 5. Key Players of DPC-005
Table 6. Key Players of Others
Table 7. Global Hemagglutinin 5 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hemagglutinin 5 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hemagglutinin 5 Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hemagglutinin 5 Market Share by Regions (2016-2021)
Table 11. Global Hemagglutinin 5 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hemagglutinin 5 Market Share by Regions (2022-2027)
Table 13. Hemagglutinin 5 Market Trends
Table 14. Hemagglutinin 5 Market Drivers
Table 15. Hemagglutinin 5 Market Challenges
Table 16. Hemagglutinin 5 Market Restraints
Table 17. Global Hemagglutinin 5 Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hemagglutinin 5 Market Share by Players (2016-2021)
Table 19. Global Top Hemagglutinin 5 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemagglutinin 5 as of 2020)
Table 20. Ranking of Global Top Hemagglutinin 5 Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hemagglutinin 5 Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hemagglutinin 5 Product Solution and Service
Table 24. Date of Enter into Hemagglutinin 5 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemagglutinin 5 Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hemagglutinin 5 Revenue Market Share by Type (2016-2021)
Table 28. Global Hemagglutinin 5 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hemagglutinin 5 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hemagglutinin 5 Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hemagglutinin 5 Revenue Market Share by Application (2016-2021)
Table 32. Global Hemagglutinin 5 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hemagglutinin 5 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hemagglutinin 5 Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hemagglutinin 5 Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hemagglutinin 5 Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hemagglutinin 5 Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hemagglutinin 5 Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hemagglutinin 5 Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hemagglutinin 5 Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hemagglutinin 5 Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hemagglutinin 5 Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hemagglutinin 5 Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hemagglutinin 5 Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hemagglutinin 5 Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hemagglutinin 5 Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hemagglutinin 5 Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hemagglutinin 5 Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hemagglutinin 5 Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hemagglutinin 5 Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hemagglutinin 5 Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hemagglutinin 5 Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hemagglutinin 5 Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hemagglutinin 5 Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hemagglutinin 5 Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hemagglutinin 5 Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hemagglutinin 5 Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hemagglutinin 5 Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hemagglutinin 5 Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hemagglutinin 5 Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hemagglutinin 5 Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hemagglutinin 5 Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hemagglutinin 5 Market Size by Country (2022-2027) & (US$ Million)
Table 64. Altravax, Inc. Company Details
Table 65. Altravax, Inc. Business Overview
Table 66. Altravax, Inc. Hemagglutinin 5 Product
Table 67. Altravax, Inc. Revenue in Hemagglutinin 5 Business (2016-2021) & (US$ Million)
Table 68. Altravax, Inc. Recent Development
Table 69. Ilyang Pharmaceutical Co., Ltd Company Details
Table 70. Ilyang Pharmaceutical Co., Ltd Business Overview
Table 71. Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Product
Table 72. Ilyang Pharmaceutical Co., Ltd Revenue in Hemagglutinin 5 Business (2016-2021) & (US$ Million)
Table 73. Ilyang Pharmaceutical Co., Ltd Recent Development
Table 74. Inovio Pharmaceuticals, Inc. Company Details
Table 75. Inovio Pharmaceuticals, Inc. Business Overview
Table 76. Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Product
Table 77. Inovio Pharmaceuticals, Inc. Revenue in Hemagglutinin 5 Business (2016-2021) & (US$ Million)
Table 78. Inovio Pharmaceuticals, Inc. Recent Development
Table 79. NewLink Genetics Corporation Company Details
Table 80. NewLink Genetics Corporation Business Overview
Table 81. NewLink Genetics Corporation Hemagglutinin 5 Product
Table 82. NewLink Genetics Corporation Revenue in Hemagglutinin 5 Business (2016-2021) & (US$ Million)
Table 83. NewLink Genetics Corporation Recent Development
Table 84. Vaxine Pty Ltd Company Details
Table 85. Vaxine Pty Ltd Business Overview
Table 86. Vaxine Pty Ltd Hemagglutinin 5 Product
Table 87. Vaxine Pty Ltd Revenue in Hemagglutinin 5 Business (2016-2021) & (US$ Million)
Table 88. Vaxine Pty Ltd Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemagglutinin 5 Market Share by Type: 2020 VS 2027
Figure 2. VGX-3400X Features
Figure 3. IY-7640 Features
Figure 4. INO-3510 Features
Figure 5. DPC-005 Features
Figure 6. Others Features
Figure 7. Global Hemagglutinin 5 Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. House Use Case Studies
Figure 11. Hemagglutinin 5 Report Years Considered
Figure 12. Global Hemagglutinin 5 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hemagglutinin 5 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hemagglutinin 5 Market Share by Regions: 2020 VS 2027
Figure 15. Global Hemagglutinin 5 Market Share by Regions (2022-2027)
Figure 16. Global Hemagglutinin 5 Market Share by Players in 2020
Figure 17. Global Top Hemagglutinin 5 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemagglutinin 5 as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hemagglutinin 5 Revenue in 2020
Figure 19. Global Hemagglutinin 5 Revenue Market Share by Type (2016-2021)
Figure 20. Global Hemagglutinin 5 Revenue Market Share by Type (2022-2027)
Figure 21. North America Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hemagglutinin 5 Market Share by Type (2016-2027)
Figure 23. North America Hemagglutinin 5 Market Share by Application (2016-2027)
Figure 24. North America Hemagglutinin 5 Market Share by Country (2016-2027)
Figure 25. United States Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hemagglutinin 5 Market Share by Type (2016-2027)
Figure 29. Europe Hemagglutinin 5 Market Share by Application (2016-2027)
Figure 30. Europe Hemagglutinin 5 Market Share by Country (2016-2027)
Figure 31. Germany Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hemagglutinin 5 Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hemagglutinin 5 Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hemagglutinin 5 Market Share by Region (2016-2027)
Figure 41. China Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hemagglutinin 5 Market Share by Type (2016-2027)
Figure 49. Latin America Hemagglutinin 5 Market Share by Application (2016-2027)
Figure 50. Latin America Hemagglutinin 5 Market Share by Country (2016-2027)
Figure 51. Mexico Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hemagglutinin 5 Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hemagglutinin 5 Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hemagglutinin 5 Market Share by Country (2016-2027)
Figure 57. Turkey Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hemagglutinin 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Altravax, Inc. Revenue Growth Rate in Hemagglutinin 5 Business (2016-2021)
Figure 61. Ilyang Pharmaceutical Co., Ltd Revenue Growth Rate in Hemagglutinin 5 Business (2016-2021)
Figure 62. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Hemagglutinin 5 Business (2016-2021)
Figure 63. NewLink Genetics Corporation Revenue Growth Rate in Hemagglutinin 5 Business (2016-2021)
Figure 64. Vaxine Pty Ltd Revenue Growth Rate in Hemagglutinin 5 Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のイクサベピロン市場規模・現状・予測（2021年-2027年）

Global Ixabepilone Market Size, Status and Forecast 2021-2027
QFJ1-5813 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、イクサベピロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（15MG/VIAL、45MG/VIAL）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のアリスキレン市場規模・現状・予測（2021年-2027年）

Global Aliskiren Market Size, Status and Forecast 2021-2027
QFJ1-5571 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アリスキレンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（150mg錠、300mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のアーユルヴェーダ病院市場規模・現状・予測（2021年-2027年） Ayurveda Hospital very effectively provides excellent Ayurveda treatments and it has a group of Ayurveda Doctors (Vaidyas) who strictly follows traditional methods and systems. Market Analysis and Insights: Global Ayurveda Hospital Market The global Ayurveda Hospital market size is projected to reac…
世界のプレハブハウス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prefab House Market The global Prefab House market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant…
世界の往診市場規模・現状・予測（2021年-2027年） A house call is medical consultation performed by a doctor or other healthcare professionals visiting the home of a patient or client, instead of the patient visiting the doctor's clinic or hospital. In some locations, families used to pay dues to a particular practice to underwrite house calls. Mar…
世界の医療往診市場規模・現状・予測（2021年-2027年） A medical house call is medical consultation performed by a doctor or other healthcare professionals visiting the home of a patient or client, instead of the patient visiting the doctor's clinic or hospital. In some locations, families used to pay dues to a particular practice to underwrite house ca…
世界の動物用ウェルネス市場規模・現状・予測（2021年-2027年） Veterinary wellness are services provided by veterinary hospitals and veterinary clinics to improve the health of veterinary animals. Under veterinary wellness, veterinary hospitals and clinics launch various plans and programmes by collaborating with various veterinary associations. Market Analysi…